Marti McKinley

Statistics

Publications

Citations

644

H-Index

Active since

2004

Affiliations

Cancer Research And Biostatistics(Current)

Saint Vincent Health System

Millennium Engineering and Integration (United States)

Research Network (United States)

Cedars-Sinai Medical Center

Marti McKinley is an author at Cancer Research And Biostatistics specializing in medicine, hematologic malignancy therapy, and multiple myeloma therapy.

Publications per year

2004–2016

Publications

Bortezomib therapy alone and in combination with dexamethasone for previously untreated symptomatic multiple myeloma

Sundar Jagannath, Brian G.M. Durie, Jeffrey L. Wolf et al. · British Journal of Haematology · 2005 · 399 citations · Full text

Medicine, Oncology, Pharmacotherapy +13

Extended follow‐up of a phase 2 trial of bortezomib alone and in combination with dexamethasone for the frontline treatment of multiple myeloma

Sundar Jagannath, Brian G.M. Durie, Jeffrey L. Wolf et al. · British Journal of Haematology · 2009 · 56 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +15

Long-Term Follow-Up of Patients Treated with Bortezomib Alone and in Combination with Dexamethasone as Frontline Therapy for Multiple Myeloma.

Sundar Jagannath, Brian G.M. Durie, Jeffrey L. Wolf et al. · Blood · 2006 · 39 citations

Medicine, Hematology, Pharmacotherapy +12

Phase 2 study of two sequential three‐drug combinations containing bortezomib, cyclophosphamide and dexamethasone, followed by bortezomib, thalidomide and dexamethasone as frontline therapy for multiple myeloma

William Bensinger, Sundar Jagannath, Robert Vescio et al. · British Journal of Haematology · 2009 · 36 citations

Medicine, Pharmacology, Pharmacotherapy +15

A Multi-Center Phase I/II Trial of Carfilzomib and Pomalidomide with Dexamethasone (Car-Pom-d) in Patients with Relapsed/Refractory Multiple Myeloma

Jatin J. Shah, Edward A. Stadtmauer, Rafat Abonour et al. · Blood · 2012 · 31 citations

Medicine, Oncology, Pharmacotherapy +14

1–5 of 9